<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/536F6788-0681-4082-8BBB-AC7D31E57B51"><gtr:id>536F6788-0681-4082-8BBB-AC7D31E57B51</gtr:id><gtr:name>MRC Epidemiology Unit</gtr:name><gtr:address><gtr:line1>MRC Epidemiology Unit</gtr:line1><gtr:line2>Elsie Widdowson Laboratory</gtr:line2><gtr:line3>120 Fulbourn Road</gtr:line3><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/536F6788-0681-4082-8BBB-AC7D31E57B51"><gtr:id>536F6788-0681-4082-8BBB-AC7D31E57B51</gtr:id><gtr:name>MRC Epidemiology Unit</gtr:name><gtr:address><gtr:line1>MRC Epidemiology Unit</gtr:line1><gtr:line2>Elsie Widdowson Laboratory</gtr:line2><gtr:line3>120 Fulbourn Road</gtr:line3><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/161DE809-8AE4-4978-9F68-F106C8C63ED0"><gtr:id>161DE809-8AE4-4978-9F68-F106C8C63ED0</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wareham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_EX_MR%2FL100002%2F1"><gtr:id>83E45442-2FD8-4D14-AF37-65983DFC202C</gtr:id><gtr:title>Part of the Cambridge Initiative in metabolic science to enhance the Epidemiology Unit?s existing research programmes.</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_EX_MR/L100002/1</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>For research into biomarkers for diabetes.</gtr:technicalSummary><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2500000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>842BB2DA-6727-473A-AD15-B8CAAD88AA87</gtr:id><gtr:title>Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>588b69e16bb077.62218666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA5FAD29-8F31-4D5D-9CF8-570D59C7A863</gtr:id><gtr:title>Associations between body mass index-related genetic variants and adult body composition: The Fenland cohort study.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568f6fceb52b74fcccb8eaabdb0b8b7c"><gtr:id>568f6fceb52b74fcccb8eaabdb0b8b7c</gtr:id><gtr:otherNames>Clifton EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>58b00833c12ac8.76197404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93F5A68F-96D9-421C-9C97-CD9E5CF3D13F</gtr:id><gtr:title>Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28bd948d23d5ea4c104c8d1477f6bc70"><gtr:id>28bd948d23d5ea4c104c8d1477f6bc70</gtr:id><gtr:otherNames>Wright DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a616862ed33f4.46515825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E926BB-95F6-4727-BDD9-D42F7AA85696</gtr:id><gtr:title>Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96ed4c140d487c8ab44c0ba517fb7439"><gtr:id>96ed4c140d487c8ab44c0ba517fb7439</gtr:id><gtr:otherNames>Zheng JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn><gtr:outcomeId>5a2fd891977549.94906223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58B837F5-227F-4814-8EDE-8A8649F1F19F</gtr:id><gtr:title>DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7c3ec8146de5404e9567cbde1b208be"><gtr:id>c7c3ec8146de5404e9567cbde1b208be</gtr:id><gtr:otherNames>Ligthart S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58b00834ab1464.87972468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBFE6659-6F9F-4C5B-B3FB-DE6D4667D48C</gtr:id><gtr:title>Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567db690855d772e533bdfe18ff48de3"><gtr:id>567db690855d772e533bdfe18ff48de3</gtr:id><gtr:otherNames>Li SX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>5a6169148b2560.29349277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A81A012-7089-442A-AF61-C6FFA6B4C7B1</gtr:id><gtr:title>Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f720dcd2f55f0fc679fcf950b375745"><gtr:id>7f720dcd2f55f0fc679fcf950b375745</gtr:id><gtr:otherNames>Day FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a616bc583d6a8.31539533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>379FF519-24C3-4A61-80EC-35BEEC15BE77</gtr:id><gtr:title>Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c923171ed63cdafd62fd629e173ce478"><gtr:id>c923171ed63cdafd62fd629e173ce478</gtr:id><gtr:otherNames>Mardinoglu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>5a616e26b519c9.59415953</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_MR/L100002/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>